News

The new deal covers several major European countries, such as Germany, France, the UK, Spain, Austria, the Netherlands and Belgium. Under the deal, Meda is responsible to pay

The funding will also support the company in conducting a first-in-man dose ranging study to evaluate the anthrax vaccine. Vaxin president and CEO Bill Enright said this is

The study aimed to establish whether the immunogenicity of two doses of Heplisav was non-inferior/superior to three doses of Engerix-B by comparing seroprotection rates (SPRs) at eight weeks

ACZ885 is a fully human monoclonal antibody that inhibits IL-1 beta, which is an important part of the body’s immune system defenses In the study, ACZ885 was generally

The trial results showed BMD at the lumbar spine and total hip increased on average by 16.8% and 6.9% in comparison to baseline, respectively. The Phase 2 extension

The company’s decision is backed by the company’s growth in the healthcare inductry from its origins in prescription drug pricing and purchasing technology to its expansion into broader

Researchers used the Roche’s cardio instrument to carry out dose-response profiling of 60 pharmaceutical drugs including the drugs withdrawn from the market due to TdP arrhythmia, hERG trafficking

Hiroshi Yamazaki has joined as a regional director of EvaluatePharma Japan KK, who will be responsible for development of EvaluatePharma’s business in Japan. EvaluatePharmaAlpha offers an off-the-shelf valuation

The rise was mainly attributable to year-over-year increase in average selling prices of the company’s products and the growing market acceptance of the Company’s new products introduced in